VC Masha Bucher, Epstein associate and Day One founder, explains herself

Masha Bucher, the founder of venture capital firm Day One Ventures, issued an extensive public statement on X (formerly Twitter) on August 21, 2024, to address mounting scrutiny regarding her historical business and personal ties to the late convicted sex offender Jeffrey Epstein. The clarification comes after a series of investigative reports detailed her involvement in Epstein’s inner circle, prompting the venture capitalist to distance herself from his criminal legacy. Bucher, formerly known as Masha Drokova, sought to provide context for her past interactions, which have resurfaced and threatened to overshadow her current standing in the Silicon Valley technology ecosystem. In her detailed response, Bucher described her younger self as an ambitious newcomer who was unaware of the gravity of Epstein's crimes at the time of their introduction. She maintained that her relationship with him was strictly professional and focused on networking within the high-stakes world of international finance and technology. However, journalistic investigations have previously highlighted that Bucher was not only a frequent guest at Epstein’s properties but also received significant professional support from him, including a green card sponsorship through one of his entities. The controversy has sent ripples through the venture capital community, where Day One Ventures has established itself as a prominent player with investments in high-profile startups. Bucher’s statement emphasized her commitment to transparency and her regret over the association, framing the period as a developmental era where she lacked the discernment to vet her associates properly. This public defense is seen as a strategic move to reassure Limited Partners (LPs) and portfolio founders who may be concerned about the reputational risks associated with Epstein’s extensive and toxic network. Despite her attempts to move past the scandal, the tech industry continues to grapple with the fallout of Epstein’s influence. Critics argue that the elite circles of venture capital often prioritize access and capital over ethical due diligence, a sentiment echoed by the continued emergence of ties between the disgraced financier and prominent figures in science and business. Bucher’s explanation serves as a rare direct confrontation of these allegations by a person directly named in Epstein’s records, highlighting the lasting impact of his shadow on modern innovation and investment leadership.